Navigation Links
COPAN Announces Workshop on Automated Specimen Processing, Digital Workup and Reporting in Microbiology During AACC Clinical Lab Expo
Date:7/19/2011

MURRIETA, Calif., July 19, 2011 /PRNewswire/ -- COPAN will be holding a workshop on Automated Specimen Processing in Microbiology during AACC's Annual Meeting. The workshop will be held at the Hyatt Regency Atlanta on Tuesday, July 26th at 7:00 AM. This program is approved for 1.5 ACCENT® Continuing Education credits. Registration for the workshop is free of charge and open to AACC attendees (http://conta.cc/jI0TSV).

Norman Sharples, COPAN Diagnostics' Executive VP, discusses today's challenges in Microbiology and the move towards liquid based samples. Liquid Based Microbiology, LBM, opens the door to specimen standardization and streamlined processing, similar to that seen in Chemistry and Hematology. He will present what these changes mean for automated specimen processing in Microbiology, especially related to revolutionary remote Bacteriology through WASPLab™ image acquisition and analysis. The presentation will examine the dramatic impact on microbiology efficiency and turn-around-time for results of the ability to view, workup, and report cultures remotely from anywhere with internet access.

Also at AACC, COPAN will highlight its global partnership with Siemens MicroScan® for the distribution of COPAN's line of automation. "The distribution agreement with Siemens MicroScan® portfolio complements COPAN's vision of converging technologies to improve front-end workflow in Bacteriology," says Norman Sharples. "This agreement is particularly exciting for the US hospital market as it merges Siemens' strong reputation in Microbiology with COPAN's innovation," concludes Sharples.

About COPAN Group

With a reputation for innovation in preanalytics, COPAN is the leading manufacturer of collection and transport systems in the world. COPAN offers a line of automation and microbial sampling products used for traditional culture analysis and molecular diagnostic assays. For more information, visit www.copanusa.com


'/>"/>
SOURCE COPAN Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Copan Announces the Appointment of Bob Cooper as Vice President of Business Development in the Pacific Rim
2. Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor
3. Copan Announces Multimillion Expansion for US Pipet Manufacturing Operations
4. Copan Installs Milestone 30th Walk-Away Specimen Processor (WASP)
5. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
6. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
7. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
8. Anesiva Announces Second Quarter 2008 Financial Results and Update
9. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
10. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
11. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Fla. , Feb. 16, 2017  MDNA ... revolutionizing the development of liquid biopsy tests based ... entered into an exclusive license agreement with its ... MDNA,s proprietary liquid biopsy test for prostate cancer, ... South Korea . This is the first ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... Feb. 16, 2017  Champions Oncology, Inc. (NASDAQ: ... and sale of advanced technology solutions and products to ... announced the addition of new cohorts of PDX models ... models will expand Champions, product line in hepatocellular cancer, ... cancer, AML, and non-small cell lung cancer (including EGFR ...
(Date:2/16/2017)... and NEW YORK , Feb. ... near completion of their $7M Series B financing, adding ... of the $3.5M led by Mesa Verde Venture Partners ... These resources will be directed towards further accelerating commercial ... a comprehensive genomic profiling test and expanding the Paradigm ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):